ARCHIVES

RFAs available: Chemoprevention Clinical Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 29 | July 22, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: Glantz, Waxman, Wigand honored For Work Opposing tobacco; CTRC Names Executives

February 16, 1996

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

ACS Research Grants Hit $78.2 Million

July 18, 1986

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization

January 28, 2011

Letters: Broder Response To Waxman Called Political Back-Pedaling

February 11, 1994